Post by PressRelease on Dec 10, 2024 7:31am
New Press Release - Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Comment by
lscfa on Dec 10, 2024 10:38am
Mgmt says phase1 should be done by mid 2025